The Effect of Concentrated Pomegranate Juice Consumption on Lipid Profile and Inflammatory Factors in Patients With Type 2 Diabetes
- Conditions
- Type 2 Diabetes
- Interventions
- Other: 50 gr concentrated pomegranate juice
- Registration Number
- NCT02024516
- Lead Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Brief Summary
The aim of this study is to examine the effects of concentrated pomegranate juice on serum lipid profile and some inflammatory factors in patients with type 2 diabetes. Forty patients aged between 25-60 years old from both sexes are recruited. Patients consume 50gr/day concentrated pomegranate juice for 4 weeks. Anthropometric and blood pressure measurements, 3-days food-record questionnaire ,physical activity and fasting blood samples were collected at the beginning and at the end of the study. Fasting blood sugar, lipid profile, TNF- a, IL-6,hs -CRP and adiponectin levels are measured. LDL are calculated by formula. The participants are asked not to change their regular diet, medicine and activity during the study.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- Not specified
- male or female 25 to 60 years old
- having type 2 diabetes for at least 6 month
- pregnancy
- lactation
- cardiac disease
- hepatic disease
- respiratory disease
- chronic renal diseases
- acute or chronic inflammation
- retinopathy
- intake of antioxidant supplement
- insulin therapy
- sensitivity to concentrated pomegranate juice
- change oral drug for controlling blood glucose
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description 50 gr concentrated pomegranate juice 50 gr concentrated pomegranate juice -
- Primary Outcome Measures
Name Time Method adiponectin change Baseline and after 4 weeks Triglyceride change Baseline and after 4 weeks HDL- Cholesterol change Baseline and after 4 weeks Total Cholesterol change Baseline and after 4 weeks hsCRP change Baseline and after 4 weeks TNF- α change Baseline and after 4 weeks IL-6 change Baseline and after 4 weeks LDL- Cholesterol change Baseline and after 4 weeks
- Secondary Outcome Measures
Name Time Method Fasting Blood Sugar change baseline and after 4 weeks Body Mass Index change baseline and after 4 weeks Blood Pressure change Baseline and after 4 weeks
Trial Locations
- Locations (1)
Ahvaz Jundishapoor University of Medical Sciences
🇮🇷Ahvaz, Khoozestan, Iran, Islamic Republic of